Parasitic Diseases
Recent clinical, regulatory, research and industry developments relating to this disease.
Trained immunity: a cutting edge approach for designing novel vaccines against parasitic diseases?
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- Active recent publication activity.
- 1 clinical trial with recent milestones (1 completed or reporting results).
Research HighlightsViewHide
Clinical MilestonesViewHide
- 2025-12-10ClinicalAn Open Label Phase 1b Study to Characterise the Pharmacokinetic/Pharmacodynamic Relationship and Safety of MMV367 in Healthy Adult Participants Experimentally Infected With Blood Stage Plasmodium FalciparumResults posted
- 2025-09-29ResearchImmunology of vector-borne diseases: the role of immunopharmacology in controlling viral and parasitic infections.Abbasi E · 2025
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Parasitic Diseases3
- Communicable Diseases1
- Disease Reservoirs1
- Health Status1
- Parasites1
- Self Report1
- Vaccines1
- Vector Borne Diseases1
Leading journals5
- BMC infectious diseases1
- Emerging infectious diseases1
- Frontiers in immunology1
- Intensive care medicine1
- Public health1
Leading researchers8
- Aavik T1
- Abad-Villaverde B1
- Abbasi E1
- Afhami R1
- Aguilar L1
- Akello G1
- Al-Shawaf L1
- Antfolk J1
Affiliations (unnormalised)6
- Aarhus University1
- Åbo Akademi University1
- Alex Ekwueme Federal University1
- Alexandria University1
- Autonomous University of Madrid1
- Bursa Technical University1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Parasitic diseases are infections or infestations caused by parasites. They are often acquired through contact with an intermediate vector, although direct exposure can also lead to infection.
They are caused by infection or infestation with parasites. The grounding also indicates that wildlife can serve as a reservoir for zoonotic infections and that vector-borne transmission is an important route for some parasitic diseases.
The literature emphasizes interactions among the parasite, any vector, and the host immune response. Innate immunity is highlighted as important, with parasites and their derived molecules able to suppress or down-regulate anti-infectious immunity and evade host defenses.
Exposure to vectors or direct exposure to parasites increases risk. Wildlife reservoirs and zoonotic transmission are also relevant risk contexts, and immunocompromised status may complicate severe infectious presentations.
Management is described at the level of prevention and control, epidemiology, drug therapy, and immunology. The grounding supports a broad approach that includes surveillance, laboratory capability, research, training, education, communication, and interdisciplinary control measures, along with drug therapy and immunologically informed strategies such as host-directed interventions and vaccine development.
AI-generated summary grounded in MeSH and 4 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Infections or infestations with PARASITES. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.